Olivia McDonald
Family · Covington, LANPI 1023649746
Payments from drug & device makers
Across 341 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$445
- GSK$406
- Lilly USA, LLC$394
- Pfizer$376
- Noven Therapeutics, LLC$374
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,142100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,090 |
| Novo Nordisk | 34 | $445 |
| GSK | 24 | $406 |
| Lilly USA, LLC | 23 | $394 |
| Pfizer | 22 | $376 |
| Noven Therapeutics, LLC | 21 | $374 |
| Sunovion Pharmaceuticals Inc. | 18 | $340 |
| Amgen(2 entities) | 19 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $267 |
| Bayer | 10 | $258 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $232 |
| AstraZeneca | 9 | $155 |
| Supernus Pharmaceuticals, Inc. | 5 | $136 |
| Astellas Pharma US Inc | 8 | $134 |
| Corcept Therapeutics | 6 | $113 |
| Kowa Pharmaceuticals America, Inc. | 6 | $110 |
| Jazz Pharmaceuticals Inc. | 5 | $110 |
| Johnson & Johnson | 3 | $103 |
| Alkermes, Inc. | 5 | $98 |
| Boehringer Ingelheim | 6 | $91 |
| Intra-sana Laboratories | 2 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $62 |
| Eisai Inc. | 3 | $56 |
| Novartis | 2 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Renalytix AI, Inc. | 2 | $42 |
| Nevro Corp. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Dexcom, Inc. | 2 | $32 |
| Indivior Inc. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $26 |
| Corium, LLC | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Qiagen, LLC | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$125
How this compares
$6,142 in reported general payments places this provider in the 90th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 39 | $70,028 |
| OzempicSemaglutide | 33 | $40,052 |
| JardianceEmpagliflozin | 11 | $18,730 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 16 | $13,972 |
| RybelsusSemaglutide | 14 | $11,677 |
| EliquisApixaban | 12 | $6,824 |
| GlyxambiEmpagliflozin/Linagliptin | 11 | $6,101 |
| SynthroidLevothyroxine Sodium | 50 | $5,491 |
| Testosterone Cypionate | 17 | $1,795 |
| ProgesteroneProgesterone, Micronized | 23 | $969 |
| Liothyronine Sodium | 20 | $897 |
| ValacyclovirValacyclovir Hcl | 18 | $847 |
| Losartan Potassium | 49 | $792 |
| Droplet Pen NeedlePen Needle, Diabetic | 14 | $765 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $754 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $394 | $70,02839 claims |
| Novo NordiskOzempic, Rybelsus | $445 | $51,73047 claims |
| Boehringer IngelheimJardiance, Trijardy Xr, Glyxambi | $91 | $38,80338 claims |
| PfizerEliquis | $376 | $6,82412 claims |
| AbbVieSynthroid | $1,090 | $5,49150 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $25738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,610 family providers in Louisiana.
Other family in Covington
- Karolina RuthnerCovington$17K
- Pamela EganCovington$15K
- Jeffrey KitchCovington$13K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.